These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 12595863

  • 1. Effect of atorvastatin and pravastatin on serum C-reactive protein.
    Kent SM, Flaherty PJ, Coyle LC, Markwood TT, Taylor AJ.
    Am Heart J; 2003 Feb; 145(2):e8. PubMed ID: 12595863
    [Abstract] [Full Text] [Related]

  • 2. Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia.
    Joukhadar C, Klein N, Prinz M, Schrolnberger C, Vukovich T, Wolzt M, Schmetterer L, Dorner GT.
    Thromb Haemost; 2001 Jan; 85(1):47-51. PubMed ID: 11204586
    [Abstract] [Full Text] [Related]

  • 3. Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis.
    Dornbrook-Lavender KA, Joy MS, Denu-Ciocca CJ, Chin H, Hogan SL, Pieper JA.
    Pharmacotherapy; 2005 Mar; 25(3):335-44. PubMed ID: 15843280
    [Abstract] [Full Text] [Related]

  • 4. Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study.
    Macin SM, Perna ER, Farías EF, Franciosi V, Cialzeta JR, Brizuela M, Medina F, Tajer C, Doval H, Badaracco R.
    Am Heart J; 2005 Mar; 149(3):451-7. PubMed ID: 15864233
    [Abstract] [Full Text] [Related]

  • 5. The comparison of the effects of standard 20 mg atorvastatin daily and 20 mg atorvastatin every other day on serum LDL-cholesterol and high sensitive C-reactive protein levels.
    Keleş T, Akar Bayram N, Kayhan T, Canbay A, Sahin D, Durmaz T, Ozdemir O, Aydoğdu S, Diker E.
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):407-12. PubMed ID: 19103535
    [Abstract] [Full Text] [Related]

  • 6. Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients.
    Joy MS, Dornbrook-Lavender KA, Chin H, Hogan SL, Denu-Ciocca C.
    Ann Pharmacother; 2008 Jan; 42(1):9-15. PubMed ID: 18000162
    [Abstract] [Full Text] [Related]

  • 7. The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia.
    Saklamaz A, Comlekci A, Temiz A, Caliskan S, Ceylan C, Alacacioglu A, Yesil S.
    Metabolism; 2005 May; 54(5):677-81. PubMed ID: 15877299
    [Abstract] [Full Text] [Related]

  • 8. Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.
    Pearson T, Ballantyne C, Sisk C, Shah A, Veltri E, Maccubbin D.
    Am J Cardiol; 2007 Jun 15; 99(12):1706-1713. PubMed ID: 17560879
    [Abstract] [Full Text] [Related]

  • 9. Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis.
    Giraldez RR, Giugliano RP, Mohanavelu S, Murphy SA, McCabe CH, Cannon CP, Braunwald E.
    J Am Coll Cardiol; 2008 Sep 09; 52(11):914-20. PubMed ID: 18772061
    [Abstract] [Full Text] [Related]

  • 10. One-year atorvastatin treatment in hypercholesterolemic patients with or without carotid artery disease.
    Avellone G, Di Garbo V, Abruzzese G, Campisi D, De Simone R, Raneli G, Licata G.
    Int Angiol; 2006 Mar 09; 25(1):26-34. PubMed ID: 16520721
    [Abstract] [Full Text] [Related]

  • 11. Design and rationale of the ARBITER trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol)--a randomized trial comparing the effects of atorvastatin and pravastatin on carotid artery intima-media thickness.
    Markwood TT, Kent SM, Coyle LC, Flaherty PJ, O'Malley PG, Taylor AJ.
    Am Heart J; 2001 Mar 09; 141(3):342-7. PubMed ID: 11231429
    [Abstract] [Full Text] [Related]

  • 12. hsCRP and HDL effects of statins trial (CHEST): rapid effect of statin therapy on C-reactive protein and high-density lipoprotein levels A clinical investigation.
    Ansell BJ, Watson KE, Weiss RE, Fonarow GC.
    Heart Dis; 2003 Mar 09; 5(1):2-7. PubMed ID: 12549983
    [Abstract] [Full Text] [Related]

  • 13. Atorvastatin affects C-reactive protein levels in patients with coronary artery disease.
    Karaca I, Ilkay E, Akbulut M, Yavuzkir M, Pekdemir M, Akbulut H, Arslan N.
    Curr Med Res Opin; 2003 Mar 09; 19(3):187-91. PubMed ID: 12803732
    [Abstract] [Full Text] [Related]

  • 14. C-reactive protein levels and outcomes after statin therapy.
    Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E, Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators.
    N Engl J Med; 2005 Jan 06; 352(1):20-8. PubMed ID: 15635109
    [Abstract] [Full Text] [Related]

  • 15. Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial.
    Ridker PM, Morrow DA, Rose LM, Rifai N, Cannon CP, Braunwald E.
    J Am Coll Cardiol; 2005 May 17; 45(10):1644-8. PubMed ID: 15893181
    [Abstract] [Full Text] [Related]

  • 16. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun 17; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 17. The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans.
    Ky B, Burke A, Tsimikas S, Wolfe ML, Tadesse MG, Szapary PO, Witztum JL, FitzGerald GA, Rader DJ.
    J Am Coll Cardiol; 2008 Apr 29; 51(17):1653-62. PubMed ID: 18436117
    [Abstract] [Full Text] [Related]

  • 18. Effects of atorvastatin and pravastatin on glucose tolerance, adipokine levels and inflammatory markers in hypercholesterolaemic patients.
    Ando H, Sugimoto K, Yanagihara H, Tsuruoka S, Saito T, Takamura T, Kaneko S, Fujimura A.
    Clin Exp Pharmacol Physiol; 2008 Sep 29; 35(9):1012-7. PubMed ID: 18430053
    [Abstract] [Full Text] [Related]

  • 19. Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial.
    Nissen SE.
    Am J Cardiol; 2005 Sep 05; 96(5A):61F-68F. PubMed ID: 16126025
    [Abstract] [Full Text] [Related]

  • 20. The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis.
    Kuryata OV, Yegorova YV.
    Kardiol Pol; 2006 Jan 05; 64(1):44-8; discussion 49-50. PubMed ID: 16444629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.